IFB 25019 - Naloxone
Awarded State & local contract opportunity Posted
- Solicitation number
- 2132534
- State
- New York
- Responses due
Opportunity facts
- Jurisdiction
- Point of contact
-
- Nicole Gennarelli procurements@oasas.ny.gov (518) 485-2194
Updated .
About this opportunity
The New York State Office of Addiction Services and Supports is soliciting competitive bids for FDA-approved intranasal naloxone product (4 mg per 0.1 mL solution) to be distributed to state-approved providers through an online ordering and tracking portal maintained by the awardee, with bids due May 1, 2026 by 4:00 p.m. EST. NYS OASAS intends to make one award from this IFB 25019.
The scope requires the awardee to supply FDA-approved naloxone at the specified concentration and maintain a bidder-operated online ordering and tracking system for state-approved providers and related organizations. The awardee must be an eligible organization under New York procurement rules.
The initial Purchase Authorization is anticipated at up to $8.0 million, with no guarantee of purchases; NYS OASAS reserves the right to increase the PA amount if additional naloxone is needed subject to required approvals. Any award will allow purchases on an as-needed basis. Emergent Devices Inc., located in Philadelphia, Pennsylvania, was awarded an identical or substantially similar contract within the past five years and is therefore identified as the business enterprise baseline for evaluation.
Questions were due March 20, 2026 by 4:00 p.m. EST. An amendment was posted on April 6, 2026. Questions and Answers were released on April 24, 2026. The full IFB and procurement documents are available at https://oasas.ny.gov/procurement.
Opportunity text
The New York State Office of Addiction Services and Supports (NYS OASAS) announces the release of IFB 25019 - Naloxone. The IFB can be found here: https://oasas.ny.gov/procurement and is anticipated to be posted by COB Friday, 03/06/2026. Questions and Answers were released 4/24/2026 and can be found here: Procurement and Funding Opportunities | Office of Addiction Services and Supports. *Amendment posted on 4/6/2026. Bid Submissions are due 5/1/2026 by 4:00PM EST. Through this Invitation for Bids ("IFB"), the New York State Office of Addiction Services and Supports (NYS OASAS) is seeking competitive bids from (a) eligible organization(s) to provide Food and Drug Administration (FDA) approved intranasal naloxone product, 4 mg per 0.1 mL solution, to NYS OASAS-Approved Providers and related organizations through an online ordering and tracking portal maintained by the bidder. It is the intent of NYS OASAS to make one (1) award from this procurement. Any resulting award will allow for the purchase of Naloxone on an as needed basis, with no guarantee of any purchases, and will be issued as a Purchase Authorization (PA). NYS OASAS anticipates that the initial PA will be for up to $8.0M, however NYS OASAS reserves the right to increase the PA amount if additional Naloxone is needed contingent on all required approvals. Questions are due 3/20/2026 by 4:00PM EST. Business enterprises awarded an identical or substantially similar procurement contract within the past five years: Emergent Devices Inc. P.O. Box 830402 Philadelphia, PA 19182
On GovTribe
Work this opportunity
- Track it in your pipeline
- Similar opportunities
- Ask GovTribe AI about this opportunity